Prim-O-glucosylcimifugin
CAS: 80681-45-4
Ref. 3D-MP08135
5mg | 144,00 € | ||
10mg | 217,00 € | ||
25mg | 406,00 € | ||
50mg | 633,00 € | ||
100mg | 1.033,00 € |
Información del producto
- 7-[(b-D-Glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-,(2S)-5H-furo[3,2-g][1]benzopyran-5-oneCimifugi n b-D-glucopyranoside
- (2S)-7-[(β-<span class="text-smallcaps">D</span>-Glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-5H-furo[3,2-g][1]benzopyran-5-one
- 5H-Furo[3,2-g][1]benzopyran-5-one, 7-[(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-, (2S)-
- 5H-Furo[3,2-g][1]benzopyran-5-one, 7-[(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-, (S)-
- Cimicifuga glycoside
- Cimifugin Beta-D-Glucopyranoside
Prim-O-glucosylcimifugin is a compound derived from Angelicae Dahuricae. This compound has been shown to have DNA binding activity in vitro and to inhibit the activity of an enzyme that is part of a signal pathway involved in viral replication. Prim-O-glucosylcimifugin has also been shown to be active against some infectious diseases, such as syncytial virus infection and HIV/AIDS. This compound also has anticomplement activity, which may be due to its ability to bind to C3b and C4b proteins on the surface of immune cells.
Propiedades químicas
Consulta técnica sobre: 3D-MP08135 Prim-O-glucosylcimifugin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.